Ignite Creation Date:
2024-05-06 @ 9:21 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02963389
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2016-10-13
Brief Title:
A Study to Evaluate Safety Tolerability and PharmacokineticsPharmacodynamics of Tripegfilgrastim in Pediatric Solid TumorLymphoma Patients
Sponsor:
Dong-A ST Co Ltd
Organization:
Dong-A ST Co Ltd
Study Overview
Official Title:
A Phase I Clinical Trial to Investigate the Safety Tolerability and PharmacokineticsPharmacodynamics of Tripegfilgrastim After Single Administration in Pediatric Solid TumorLymphoma Patients
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label single ascending dose study to evaluate safety tolerability and pharmacokineticspharmacodynamics of Tripegfilgrastim in pediatric solid tumorlymphoma patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None